Jan Aushadhi Scheme Achieves ₹45,000 Crore in Public Savings

New Delhi, India Jul 24, 2026 ALN: A total of 20,149 Jan Aushadhi Kendras have been opened nationwide, leading to estimated savings of about ₹45,000 crore for citizens through the Pradhan Mantri Bhartiya Janaushadhi Yojna, the government informed Parliament on Friday.

Over the past 12 years, these savings have been realized when compared to the prices of branded medicines, contributing significantly to a sharp reduction in out-of-pocket expenditure by households. Union Minister for Chemicals and Fertilizers, Jagat Prakash Nadda, highlighted this achievement in the Lok Sabha.

The Pradhan Mantri Bhartiya Janaushadhi Yojna (PMBJP) was launched with the primary aim of providing quality generic medicines at affordable prices to the citizens of India. This initiative is particularly significant in a country where healthcare costs can be a substantial burden on families, especially those from low and middle-income backgrounds. By making essential medicines available at lower prices, the scheme aims to alleviate some of this financial pressure.

The PMBJP product basket includes 2,110 medicines along with 315 surgicals, medical consumables, and devices that cover major therapeutic groups, such as cardiovascular, anti-cancer, anti-diabetic, anti-infectives, anti-allergic, and gastro-intestinal medicines, as well as nutraceuticals. This extensive range ensures that patients have access to a wide variety of necessary treatments, which can significantly enhance health outcomes.

Currently, 776 out of 784 districts in the country are covered under this program, demonstrating the extensive reach of the initiative. The remaining districts are expected to be included soon, ensuring that the benefits of the scheme are accessible to all citizens, regardless of their geographical location. This coverage is particularly important in rural and underserved areas, where access to healthcare facilities and affordable medicines can be limited.

Almost all generic medicines included in the National List of Essential Medicines are part of this product basket, with the exception of lab reagents and vaccines. The inclusion of these essential medicines underscores the government’s commitment to enhancing public health and ensuring that critical treatments are available to those who need them most.

The initiative encourages the stocking of 200 commonly used medicines, which includes the 100 top-selling medicines in the scheme's product basket and 100 fast-selling medicines in the market. Jan Aushadhi Kendra (JAK) owners are eligible for monthly incentives based on the stocks they maintain for these medicines. This incentivization not only helps maintain adequate stock levels but also encourages more entrepreneurs to open JAKs, thereby expanding the network of affordable medicine outlets across the country.

The Pharmaceuticals & Medical Devices Bureau of India (PMBI), which implements the PMBJP scheme, conducts continuous evaluations of Jan Aushadhi Kendras based on their sales performance. This evaluation, along with the overall performance of the scheme, indicates that PMBJP has significantly improved access to quality generic medicines at affordable prices across the country through a rapidly expanding network of Jan Aushadhi Kendras. The systematic assessment helps identify successful strategies and areas needing improvement, ensuring that the program remains responsive to the needs of the population.

Continuous monitoring and appropriate corrective measures are undertaken to minimize stock shortages and ensure the availability of essential medicines across the nation. This proactive approach is vital in maintaining the trust of consumers and ensuring that they can rely on JAKs for their medicinal needs. The government’s emphasis on monitoring also reflects a commitment to accountability and transparency in public health initiatives.

The Pharmaceuticals and Medical Devices Bureau of India (PMBI) also conducts awareness campaigns in coordination with various bodies and platforms such as the Central Bureau of Communication, PIB, MyGov, and MY Bharat to promote acceptability and increase the sale of medicines supplied through JAKs. These campaigns are crucial for educating the public about the benefits of generic medicines and the availability of affordable options, as many consumers may still be unaware that generic medicines can be as effective as their branded counterparts.

The success of the Jan Aushadhi Scheme has broader implications for the Indian healthcare system. By reducing the financial burden of healthcare, the scheme contributes to improved health outcomes, which can lead to increased productivity and economic growth. Furthermore, the initiative aligns with the broader goals of the Indian government to enhance healthcare access and affordability, particularly in light of the ongoing challenges posed by the COVID-19 pandemic, which has underscored the importance of accessible healthcare for all citizens.

Moreover, the PMBJP initiative can serve as a model for other countries facing similar challenges in healthcare affordability and access. The focus on generic medicines and the establishment of a robust distribution network through Jan Aushadhi Kendras could inspire similar programs worldwide, promoting global health equity.

In conclusion, the Jan Aushadhi Scheme's achievement of ₹45,000 crore in public savings is a significant milestone that highlights the importance of accessible healthcare. As the program continues to expand and evolve, it is poised to play a crucial role in shaping the future of healthcare in India, ensuring that all citizens have access to the medicines they need without facing financial hardship.

To provide further context, the Jan Aushadhi Scheme is part of a larger discourse on healthcare reform in India. The Indian healthcare system has long been characterized by high out-of-pocket expenses, with many families finding it difficult to afford necessary medications. The introduction of the PMBJP was a strategic move to address these concerns, particularly in a nation where a significant portion of the population lives below the poverty line.

Healthcare access in India is not only about the availability of medicines but also about the affordability and the quality of healthcare services. The Jan Aushadhi Kendras serve as a critical link in this chain, ensuring that essential medications are not just available but also affordable. This is particularly important in rural areas where private pharmacies may charge exorbitant prices for essential drugs, thus making them inaccessible to the poorer segments of society.

The initiative not only aims to provide cost-effective medicines but also focuses on raising awareness about the efficacy of generic drugs. Many consumers remain skeptical about generics, believing that they are inferior to branded medications. The government’s campaigns are designed to educate the public, dispelling myths and encouraging the acceptance of generic alternatives. This is crucial in changing consumer behavior and ensuring that the benefits of the scheme are fully realized.

Additionally, the Jan Aushadhi Scheme has implications for the pharmaceutical industry in India. By promoting generic medicines, the initiative encourages pharmaceutical companies to focus on quality and affordability, thus fostering a competitive market environment. This can lead to lower prices across the board, benefiting consumers and enhancing the overall healthcare landscape in India.

The success of the PMBJP is also indicative of the government's commitment to improving healthcare infrastructure. The establishment of Jan Aushadhi Kendras across the country is a step towards ensuring that healthcare is not just a privilege for the wealthy but a right for all citizens. As more Kendras open, the reach of affordable healthcare expands, which is vital in a country where health inequities are prevalent.

Looking ahead, the continued expansion of the Jan Aushadhi Scheme will require sustained government support and investment. Ensuring that these Kendras are stocked with essential medicines and that they can operate sustainably will be crucial. The government may also need to explore partnerships with local entrepreneurs and NGOs to enhance the reach and impact of the program.

In summary, the Jan Aushadhi Scheme represents a significant step forward in India's healthcare journey. With ₹45,000 crore in savings for citizens, the initiative not only alleviates the financial burden of healthcare but also promotes health equity and accessibility. As the country navigates the complexities of healthcare reform, the PMBJP stands as a beacon of hope, illustrating the potential for change when quality healthcare is made accessible to all.